1. Home
  2. LIMNW vs MTSR Comparison

LIMNW vs MTSR Comparison

Compare LIMNW & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIMNW
  • MTSR
  • Stock Information
  • Founded
  • LIMNW N/A
  • MTSR 2022
  • Country
  • LIMNW United States
  • MTSR United States
  • Employees
  • LIMNW N/A
  • MTSR N/A
  • Industry
  • LIMNW
  • MTSR
  • Sector
  • LIMNW
  • MTSR
  • Exchange
  • LIMNW Nasdaq
  • MTSR NYSE
  • Market Cap
  • LIMNW N/A
  • MTSR N/A
  • IPO Year
  • LIMNW N/A
  • MTSR 2025
  • Fundamental
  • Price
  • LIMNW $0.09
  • MTSR $28.12
  • Analyst Decision
  • LIMNW
  • MTSR Strong Buy
  • Analyst Count
  • LIMNW 0
  • MTSR 4
  • Target Price
  • LIMNW N/A
  • MTSR $47.00
  • AVG Volume (30 Days)
  • LIMNW N/A
  • MTSR 901.1K
  • Earning Date
  • LIMNW N/A
  • MTSR 05-12-2025
  • Dividend Yield
  • LIMNW N/A
  • MTSR N/A
  • EPS Growth
  • LIMNW N/A
  • MTSR N/A
  • EPS
  • LIMNW N/A
  • MTSR N/A
  • Revenue
  • LIMNW N/A
  • MTSR N/A
  • Revenue This Year
  • LIMNW N/A
  • MTSR N/A
  • Revenue Next Year
  • LIMNW N/A
  • MTSR N/A
  • P/E Ratio
  • LIMNW N/A
  • MTSR N/A
  • Revenue Growth
  • LIMNW N/A
  • MTSR N/A
  • 52 Week Low
  • LIMNW N/A
  • MTSR $12.30
  • 52 Week High
  • LIMNW N/A
  • MTSR $32.81
  • Technical
  • Relative Strength Index (RSI)
  • LIMNW N/A
  • MTSR N/A
  • Support Level
  • LIMNW N/A
  • MTSR N/A
  • Resistance Level
  • LIMNW N/A
  • MTSR N/A
  • Average True Range (ATR)
  • LIMNW 0.00
  • MTSR 0.00
  • MACD
  • LIMNW 0.00
  • MTSR 0.00
  • Stochastic Oscillator
  • LIMNW 0.00
  • MTSR 0.00

About LIMNW Liminatus Pharma Inc. Warrants

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.

Share on Social Networks: